Actonel (risedronate) is now approved for osteoporosis

Actonel (risedronate) is now approved for osteoporosis.

Actonel is a bisphosphonate...similar to Fosamax (alendronate). But until now, Actonel was approved only for Paget's disease.

The new indication is to prevent or treat osteoporosis in postmenopausal women...or in patients taking glucocorticoids.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote